Ligan, Ghilryn .
HRN: 23-91-88 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/03/2023
CEFUROXIME 500MG (TAB)
11/03/2023
11/09/2023
PO
500
BID
RMLE
Checking Final Appropriateness
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes